Tus kws kho mob
QP9-20 Pharmacy Benefit Exclusion Healthcare Administered Drugs
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 22, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2621 - 2630 ntawm 3679
Tus kws kho mob
QP15-20 Commercial Medical Drug Exclusion List Expanded to Include Avsola
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 22, 2020
Tus kws kho mob
P4-20 Lab Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
QP107-19 Medical Drug Update for Rituximab Biosimilars (Truxima, Ruxience) – Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019
Tus kws kho mob
QP105-19 Understanding Vision Benefits within Eligibility & Benefits Inquiry Response
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 11, 2019
Tus kws kho mob
QP93-19 Provider Cost Data Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
P7-20 Musculoskeletal Management Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020
Tus kws kho mob
P5-20 Cardiology & Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 02, 2020